688238 和元生物
2025/03 - 三个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(61,414)(61,068)(90,122)21,424109,308
投资活动产生之现金流量净额(60,372)(209,030)(601,553)(469,607)(76,136)
筹资活动产生之现金流量净额42,38452,209134,1201,092,87287,851
汇率变动对现金及现金等价物的影响(6)(203)(33)(60)5
现金及现金等价物净增加/(减少)(79,408)(218,093)(557,589)644,630121,028
期初现金及现金等价物余额434,894652,9871,210,576565,946444,917
期末现金及现金等价物余额355,487434,894652,9871,210,576565,946